Single-cell nanopore sequencing allows high-throughput multiomic analyses of cellular diversity in disease
- Published on: October 28 2019
Ghamdan Al-Eryani is currently completing his PhD in the Tumour Progression group located at the Garvan Institute of Medical Research in Sydney, Australia where he is developing and implementing single-cell technologies to understand how the immune system works in cancer.
During this webinar, Ghamdan shares his work using single-cell nanopore sequencing for high-throughput multiomic analyses of cellular diversity in disease.
